text stringlengths 5 11.1k |
|---|
They calculated projected clinical benefits including primary transmission, quality-adjusted life years saved, and mortality. They also calculated the cost of HIV care and PrEP as well as incremental cost-effectiveness ratios over the same 10-year period. They found that after calculating 10-year clinical outcomes, to... |
I'm Joan Stevenson, editor of JAMA's Medical News and Perspectives section. Today, this JAMA Evidence Podcast will focus on the process of diagnosis. Our guest expert is Dr. Gordon Guyatt. Dr. Guyatt, why don't you introduce yourself to our listeners? I'm a professor of medicine and of clinical epidemiology and biost... |
The Radiology Review is pleased to offer the Board Exam Study Guide, Episodes 1-101, available for purchase as a book on Amazon or in Kindle version. Welcome to the Radiology Review Podcast, your on-the-go source for radiology education with your host, Dr. Matt Covington, a board-certified radiologist. Please follow th... |
And the gastrointestinal sites are most common in general, followed by the respiratory system. Note that five-year survival is higher for small intestine neuroendocrine tumors at about 70% compared to rectal neuroendocrine tumors at about 30% for 5-year survival. Next question. True or false? Lutetium-177-dotatate is c... |
I will catch you on the next episode. Content of this podcast is provided for informal educational purposes only for radiology trainees and radiologists. Medical practitioners, please make your own independent assessment before suggesting a diagnosis or recommending any course of treatment. This podcast should not be ... |
The Curbsiders podcast is for entertainment, education, and information purposes only, and the topics discussed should not be used solely to diagnose, treat, cure, or prevent any diseases or conditions. Furthermore, the views and statements expressed on this podcast are solely those of the host and should not be interp... |
At this point, I am ready to talk about it on a podcast that is listened to internationally, which is good. So I've made some progress and I've come to look at therapy as a tool that we should be utilizing before things get worse so that we can avoid those lows. What's great about BetterHelp is that it's customized onl... |
You have extrinsic compression, you're causing venous hypertension. Reason number two, why poor Cardi B is experiencing edema. And then reason number three, and I think this is true, I've not been able to find papers to back me up on this, but you're in the air, you have lower cabin pressure. I think everyone's feet ge... |
I think my workup would probably be different if this was a 30-year-old patient with minimal past medical history as opposed to Ms. Fadima, Yeah. I would hope that you do a good JVD examination. I hope that you would look for the lateral displaced PMI and so forth and so on. You're going to look at the legs. That's alw... |
Yeah. Yeah, Z-Pak and a prednisone taper. Yeah, absolutely. Okay. Better safe than sorry, especially in your diabetic patients. You really want to make sure you load them up with steroids to calm down that inflammation. All right. Yeah. So her medication list, I'm not saying it's bad. I'm just saying that there's a lot... |
Yeah, no, I think we've made this point a bunch of times on the show. But with chronic venous insufficiency, it's a spectrum, right? So you can have someone who comes in with swelling of the legs that's cyclic and maybe worse in the summertime and it bothers them. And you try to talk them into compression stockings, wh... |
I think I'd do my initial workup, see what there is to see. What do you think about a BNP? Because I saw a BNP listed as Yeah. failure, there is some prognostic value to it. You know, you got to be more worried about patients with a high BNP. I'm not hinging the entire diagnosis on that, but sometimes I think it can be... |
And he got hooked up. He went to the lymphedema clinic. He had really horrible, very longstanding lymphedema. And the goal was just to get him like to be able to, he was having trouble just getting up and getting out of the chairs because the limbs were so heavy. And they were just, they were working and able to get hi... |
Because in those cases, patients might be candidate for intervention and they're at higher risk for, you know, the phlegmasia complications, things like that. Yeah. And I made the joke, but the reason they love it is because they can actually do something about it. Okay. There you go. There you go. So that's another o... |
From the JAMA Network, this is JAMA Internal Medicine Author Interviews, conversations with authors exploring the latest clinical research, reviews, and opinions featured in JAMA Internal Medicine. I am Dr. Robert Steinbrook, Editor-at-Large at JAMA Internal Medicine. I'm here with Dr. Aaron Kesselheim from the Brigham... |
And I think that currently they've put out a request for information on the blueprint and on other aspects of this. So they're, as we sit here today, I think still gathering information from stakeholders about what they think about this particular idea, but also on a number of other ideas that were part of that bluepr... |
I'm Rachel Gottbaum, and this is Intention to Treat from the New England Journal of Medicine. Remember the beginning of this pandemic? Now to growing concerns about the deadly coronavirus officially hitting the U.S. Here's what we know. Fast-breaking developments in the coronavirus emergency in the U.S. and around the ... |
I don't see how you can reasonably try and prevent against mild disease for any length of time for a short incubation period disease, knowing that neutralizing antibodies are not going to be long-lived. And I can't think of a strategy that would allow that to happen. The only other way that this could happen is if thi... |
Hello out there. This is Dr. Kathy DeAngelis, the editor-in-chief of JAMA, the Journal of the American Medical Association. And this week I'm going to tell you about the December 17, 2008 issue. And as usual, we'll start with the art on the cover. And this issue has one of my very favorite artists, Giuseppe Accombald... |
Hey folks, just a quick reminder that this podcast is not meant to be used for medical advice, just good old-fashioned education. Hello, Clinical Problem Solvers. Welcome. My name is Robby Jihah, and I'm a clinician educator at UCSF. We have the whole crew here today, Arsalan, Charmaine, and Reza. Hey, Arsalan, what's ... |
And we were given the diff, which was normal. And so the patient does not have an eosinophilia. but the LFT abnormalities and the rash itself and the anti-epileptic agents makes that a consideration. Those patients often also have facial edema. And a quick trick to know if someone has swelling when you're looking at th... |
The upper limit of normal was 500. The hemoglobin and platelets were normal, as was the renal panel and AUA. The ALT was 178, AST 475, and ALKFOS 194. And as a general reminder, these are slightly more elevated than they were before. A T-billy and direct bilirubin are both still normal. The INR is 1, and the albumin i... |
Hello out there. This is Dr. Kathy DeAngelis, the Editor-in-Chief of JAMA, the Journal of the American Medical Association. And this week, I'm going to tell you about the November 12, 2008 issue. And as always, I'll start with the cover. And this one's a doozy. It's a painting by Ernst Ludwig Kirchner, who lived from... |
Hello and welcome to the latest podcast for The Lancet Oncology. Richard Lane here with you on Tuesday, December the 4th. In this month's podcast, we're looking at the COBOLT trial published December the 4th, which is looking at ultrasound-guided breast conserving surgery. To find out more, I interview one of the aut... |
From the JAMA Network, this is JAMA Author Interviews, conversations with authors exploring the latest clinical research, reviews, and opinion featured in JAMA. I'm Dr. Gregory Kerfman, the executive editor of JAMA, and in this JAMA Author Interview, I'll be speaking with Dr. Ai-Min Lee. Dr. Lee is Professor of Medicin... |
They know, for example, after dinner every night, I'll go for a half-hour walk. Or they know I'm going to play tennis twice a week. Or they know, you know, I swim in the weekends. So for these people, they might prefer to monitor time instead. I personally believe that we should keep the time metric, but we should als... |
Okay, welcome to episode 86 of the Divine Intervention Podcast. In today's episode, I'm going to essentially discuss how to be an excellent intern. There are many facets to being an excellent intern, but this is just basically like a general overview of your job descriptions as an intern, especially for a medicine inte... |
And then you definitely want to learn how to read EKGs and chest x-rays. That's just an important thing you want to do as an intern. You also want to get good at presenting your patients. Again, I will encourage you, build a standardized approach. In fact, you know what, let me just combine this with another thing I gu... |
I scored in the 99th percentile, in the 95th percentile on my engineering exam. Don't disclose your test scores ever. Don't be the source of that information. If other people hear from other people, fine, whatever. But do not disclose your USMLE scores. No, just your scores are for you. They are for program directors. ... |
Make your attending's life easy. And again, these are just all means of acquiring goodwill, okay? Although, don't try to be so independent that you are then handling dangerous situations on your own without putting your attendant and your senior in the loop that can get you into trouble really quickly. Okay. So if you... |
So, I ended up actually doing a stress test on him, and it was grossly abnormal. Did an angiogram, and he had a proximal LAD significant lesion. And he ended up getting stent. Now, this is a 36-year-old, right? So, you're like, man, he's got no risk factors. So, you know, always trust yourself in what you're hearing. H... |
If I'm doing everything else, it's okay. But every single time I'm going up there. So for him, I said, okay, well, look, his risk factors, not really that much, right? He's 36. Age doesn't really count. He's got no other history. He's got no cholesterol. I double-checked his lipids. I said, you know, you're not eating,... |
I personally would probably just send him with something with imaging like Echo. Still make him walk if he can walk because I want to know how much he can do. Can you get good enough windows on a stress echo for someone who's that obese though? You'd be surprised. Sometimes imaging is worse in the thinner people becaus... |
I was going to say, one thing that I always tell my trainees is understanding the difference between ACS and CAD. And I think one of the problems that we have with a lot of these patients that are admitted for chest pain rule-outs is that the residents that we train, oftentimes on admission, they'll order that MPI or M... |
It's just not going to be as accurate. So that's the calcium scoring. But when we do CT angio, we do a calcium score first. And if there isn't significant amount, then we inject the dye and we run them again. And then we say for sure, you know, calcium score and CT angio zero for calcium, no obstructive CAD. What is th... |
Minneapolis, it's $3,400. Yeah, that's almost as much as the insurance payment for left heart cath. How much is that at cash lack? Free. It's about two weeks. It's about two weeks. Yeah. Time is money. And just a brief, you know, we talk about all these scores, like Timmy and Hart score. If you look at them, the reason... |
They excluded like patients over 75 or whatever, but it was, I thought it was interesting. So that, that's one way that like for some of my patients, if they're really like, I don't think I need a statin and if I feel strongly that they are high risk, you know, that might be for an asymptomatic patient, I might be usi... |
Welcome to the September 20, 2016 Annals of Internal Medicine podcast. I'm Dr. Christine Lane, Annals Editor-in-Chief, and I'll be sharing some highlights about new articles published since our last podcast. The first article I'd like to bring to your attention identifies three objective criteria that can quickly ident... |
Thanks to Beth Jenkinson, Megan Caffrey, and Andrew Langman for their technical support. |
Hello and welcome to the podcast for the October 2008 issue of the Lancet Infectious Diseases. Richard Lane here with TLID's editor John McConnell. Welcome John and a few items to cover this week. Let's start with something that always seems topical and that's flu vaccination but specifically this is quite interesting.... |
Great. We look forward to that. John, many thanks indeed. Those were some of the highlights from the October 2008 issue of The Lancet Infectious Diseases. Thanks for listening. See you next month. |
Hello, Richard Lane here with the Lancet podcast on Friday, May the 25th. This week's feature is about repetitive strain injury, or RSI, the topic of a seminar in this week's issue. In a moment, we'll be hearing from one of the authors of this seminar about a condition which affects millions of people worldwide. Befo... |
Hello and a very warm welcome to the first ever podcast for The Lancet Oncology. I'm Richard Lane and I'm with TLO editor Dr David Collingridge. Welcome David and we're going to discuss some highlights from the March 2008 issue of The Lancet Oncology. Let's start with a very interesting research article and this is loo... |
And in terms of results we see some pretty high satisfaction levels don't we? Yes the results were very good actually in this model. 92% of survivors agreed to participate, 98% of family doctors really wanted to be involved, and 90% of doctors returned the appropriate data to the long-term follow-up clinic. Plus, 88% ... |
This is the New England Journal of Medicine COVID-19 update for December 21st, 2022. I'm Stephen Morrissey, Managing Editor of the Journal, and I'm talking with Eric Rubin, Editor-in-Chief, and Lindsay Baden, Deputy Editor. Eric and Lindsay, I'd like to start with an announcement. In the midst of the holiday season, we... |
And this is the nature of what we have to deal with as infectious diseases spread into different communities. So I think, Eric and Steve, it's very important that we think carefully about the goalposts and yardsticks we use to determine what is beneficial and how much illness we are seeing, because circumstances have c... |
If we put our efforts in the right direction, we can tackle so many more pathogens that cause so much illness. So again, I am full of hope, but I think there are miles to go before we sleep, as I've said before. And there are many, many more medical problems we can solve with the kind of focus and energy that we have ... |
Hi, and welcome back to Sharp Scratch. You're listening to episode 70. There's no pill for homelessness. This is a podcast brought to you by the BMJ and sponsored by Medical Protection, where we bring together medical students, junior doctors and expert guests who discuss all the things you need to know to be a good do... |
At the same time it's kind of a bit of a shame that things haven't quite sort of moved on as they might because I think that our understanding of the importance of these things probably has sort of progressed and it's sort of a shame that by the sounds of it medical schools haven't quite found a means of making that ap... |
I think that understanding the contributing factors and going out of your way to understand the contributing factors as a doctor can be just as important as treating the disease in front of you, especially, you know, if, especially if you're in a kind of like more community facing role, like maybe GP or something like ... |
And so I think that if we can acknowledge their context and actually not allow that to prejudice against people unthinkingly because we're sort of stressed and we're having a difficult day, et cetera, et cetera, if we can actually sort of overcome that, even though they might be frustrating to deal with because some of... |
So what would you recommend to the listeners who may not know very much or don't know how to become more aware of things what would you recommend that they do like right now in this instance like after listening to this podcast what would you say they should do so i guess um i mean it depends because i guess everyone'... |
Welcome. This is the New England Journal of Medicine. I'm Dr. Lisa Johnson. This week, April 28, 2016, we feature articles on transcatheter versus surgical aortic valve replacement, exazomib in myeloma, Ebola vaccine trials, and an experimental approach to treating Duchenne's muscular dystrophy, a review article on vio... |
The patient was brought to the emergency department. On the initial examination, the patient was alert and followed simple commands, but answered, yuck, to all questions. A diagnosis of acute ischemic stroke due to occlusion of the left middle cerebral artery was made. A bolus of tissue plasminogen activator was admin... |
Okay, welcome. My name is Devine. I'm a resident. This is episode 206 of the Devine Intervention Podcast. And in this podcast, I'm going to begin a family medicine shelf exam rapid review series. I'll just be doing a bunch of cases that highlight topics and concepts that are commonly tested on the family medicine exam.... |
At least probably like 80% of the MBM questions I've seen on hypothyroidism, those people almost always have bradycardia, right? And you know, they will feel tired, they will gain weight, they will have like the pre-tibial myxedema and all that badness, right? And they may also have like cholesterol lab abnormalities, ... |
That's not always the case, right? So if a person has an LDL cholesterol, not total cholesterol, LDL cholesterol more than, you know, 190, right? So 190 or higher. So if it's 189, it doesn't fall. But 190 or higher, right? Go ahead and give those people a statin, right? And again, usually you give like high intensity s... |
And then what are the things you find with niacin deficiency aka pellagra right you know you have the four d's right so like diarrhea dermatitis dementia and death right so those are all things to keep at the back of your mind for exams um vitamin b5 pantheothenic acid that's step one so i'm going to skip that there's ... |
Remember, you want to avoid bloating-containing foods in those people. And then if you've drunk alcohol for a pretty long portion of your life, and then they tell you that, oh, the person has had recurrent episodes of abdominal pain, that's chronic pancreatitis, right? Pancreas is shot, no more lipase, right? So you'r... |
Welcome to the New England Journal of Medicine. I'm Dr. Michael Bierer. This week, June 4, 2015, we feature articles on high-flow oxygen in acute hypoxemic respiratory failure, follow-up of outcomes in type 2 diabetes, the promise and problems of precision medicine, the clinical genome resource, cancer-predictive Panel... |
Advances in sequencing technology have made multi-gene testing, or panel testing, a practical option when looking for genetic variants that may be associated with a risk of breast cancer. In June 2013, the U.S. Supreme Court invalidated specific claims made by Myriad Genetics with respect to the patenting of the genom... |
Hello and welcome to the Lancet Gastroenterology and Hepatology podcast in conversation with. I'm Hugh Thomas, the Deputy Editor. In this episode, we'll be discussing a series appearing on our December issue, discussing the emergence of non-alcoholic fatty liver disease in sub-Saharan Africa and the challenges it prese... |
So a real problem of diabetes and obesity. And then in southern sub-Saharan Africa, we have this added problem of HIV infection and its therapies and the metabolic consequences are potentially additive factors. And that will really drive further problems relating to non-alcoholic fatty liver disease. So probably out of... |
So what we really want to do is prevent the development. So I think we need to look at lifestyle changes. We need to look at diet. We need to look at weight loss. And I think what has been shown, despite all the other medications, that sustained weight loss has the best benefits in terms of improving the stages of NAF... |
Hello and welcome to a special episode of The Lancet Voice for Black History Month here in the UK. I'm Jessamy Baganal. And I'm Gavin Cleaver. We've got a packed show today and we're also joined on hosting and discussion duties by two of the founding members of The Lancet's Group for Racial Equality, Senior Executive E... |
We also used a number of approaches given the inequalities to not only ensure we were delivering high quality prevention programs, but to really began to deliver targeted interventions with communities in order to address these inequalities. So with the syphilis elimination effort, working together with black community... |
And I think moving forward as we move beyond the second wave we'll be having to think through at a regional level what it means for restarting economies, re-engaging and supporting communities and rebuilding and building that better as we emerge from that as well. And then finally I think as we are in the second wave w... |
He was very good with children, particularly, and he wouldn't charge poor families for his help, particularly if it involved children. And this, of course, was all before, long before the NHS in 1948. During the First World War, black soldiers who joined to fight with the British got to hear about him. Not all of them,... |
And actually, I don't think they paid a huge amount for it. It was doable, thank goodness. And so the bronze portrait came back where it should have been because it kind of mysteriously vanished in the 1960s and then suddenly turns up in New Zealand, but we won't go into that. And I said to Southern Council, now that w... |
Obviously black history is far deeper in British history. It is part of British history and Mary is a reminder of the existence of black contribution prior to Windrush because of course she was at the Crimean War and we are dealing with Victorian times in the 1800s. So it serves as a really important reminder as to how... |
Udani's, you know, very lovely person anyway, but we hit it off quite quickly because we were the only two non-white people and we chatted about it. It was the first conversation I was able to have with another colleague about it. And so then, as I said, many years even after that passed and we were still the only two... |
Hello, and welcome to this week's Annals of Internal Medicine audio summary for our December 4th, 2007 issue. I'm Michael Berkowitz, Deputy Editor at Annals. We have another exciting issue for you this week, with articles on the use of telbivudine for the treatment of chronic hepatitis B, the three medications most res... |
But I think that within the ABIM norms, there are questions about putting the interests of patients ahead of personal interests of physicians. On the behavioral side, they're not explicitly stated or as fully developed as one might like, but they definitely are there with respect to, for example, financial conflicts of... |
Let's say most internists are giving patients their flu shots and their Pneumovac shots, for example, or checking HbA1c levels in their patients with diabetes. Why is rewarding them for doing those things consistently and consistently well a problem? Okay, so the potential is that pay-for-performance programs that rely... |
Our CME article this week is an observational cohort study of about 2,000 patients with venous thromboembolism, suggesting that 4 to 9 percent will die from fatal pulmonary embolism in an average four and a half years after discontinuing anticoagulation. We have an update in oncology, the 9th of 10 updates appearing t... |
Welcome, listeners. This is Amalia Cochran. I am the web and social media editor for JAMA Surgery. I'm here today interviewing Dr. Guido Beldi, who is the senior author on a study entitled The Effectiveness of Prophylactic Intraperitoneal Mesh Implantation for Prevention of Incisional Hernia in Patients Undergoing Op... |
This is Derek Paul, and welcome to the Anti-Racism in Medicine series of the Clinical Problem Solvers podcast, where, as always, our goal is to equip our listeners at all levels of training with the consciousness and the tools to practice anti-racism in their health professions careers. Today's episode is titled Disman... |
Black and Native folks, not getting many of them. European and Asian folks, Asian folks getting slightly more. White folks perceived as the most intelligent. You have Carl Linnaeus that says that they are intelligent, they are witty, or sorry, they are smart, they are imaginative, and they are governed by laws. That wa... |
Their lung capacity doesn't seem to be equal to mine. Yeah, let me work someone nearly to death and then ask to get their lung capacity measurement and compare it to mine when I'm just watching them. And then it becomes this false idea that there is innate physiological difference. And I mentioned this point because gu... |
And so I struggle when people are like, oh, that's the black struggle. That's the Latino struggle. That's the native struggle. I feel that conversation, unfortunately, adheres to the construct that these are different people. Yes, there's different experiences. There's different maneuvering through the world. But solid... |
I think a lot of folks can understand this notion that structural racism and structural determinants of health that kind of lie upstream of the way social determinants are distributed, right? These risk factors that we understand for chronic diseases, that's maybe more believable for folks, right? Policy shapes the way... |
Yeah, that's a good question. I'm thinking where, there's so much, but I'm thinking where to start. And I actually think we have to start at home, meaning asking your classmates, our colleagues, what have you been taught at home that is allowing you to believe these things that so many of your other colleagues are tel... |
Hello, and welcome to a very special episode of the Lancet podcast. From the Lancet offices in London, my name is Nikolaj Humphries. On July 10, 2012, we published a new global health series on family planning. This Lancet series reviews the evidence of the effects of population and family planning on people's well-bei... |
Going to the policy options, one of the things we noted is the fact that in the low-fidelity regions, policy efforts have been constrained by the reluctance to interfere with individual or personal decision-making that affects childbearing within these countries. And the key policy options in these regions that have b... |
From the JAMA Network, this is the JAMA Editor's Summary, a review of important research and review articles appearing in the latest JAMA issue. Hello and welcome to this JAMA Editor's Audio Summary for our September 12, 2017 issue. This is Howard Bauchner, Editor-in-Chief of JAMA. Starting with the original research... |
Hello and welcome to the Lancet podcast for the October issue of the Lancet Infectious Diseases. I'm Richard Lane and I'm joined by TLID Senior Editor Pam Daz. Pam, the topics in two of the reviews in the October issue are being discussed at ICAC, that's the Interscience Conference on Antimicrobial Agents and Chemoth... |
Today on Sharp Scratch, you'll learn whether you ever really stopped being a doctor, how normal it is to want to leave medicine, and what actually is a portfolio career. You're listening to Sharp Scratch, episode 28, Leaving Medicine. This is a podcast brought to you by the BMJ and sponsored by Medical Protection, wher... |
And for a long time I said to people, you know, I'm a doctor, but I'm currently working as an editor. It took me about five years to stop saying that. Because a doctor is something kind of so substantial and so sort of concrete. And then I began to say I used to be a doctor and now I'm an editor. And then I stopped eve... |
Yeah. And I think that's where, I guess, Fi, you leaving clinical medicine, I suppose, may have had less of an impact on how you conceptualize your own identity in terms of the medical field, because the BMJ is so very kind of embedded into that whole world and it might be a bit different for people who leave and do so... |
And when it comes to your elective, you can trust in our international experience to protect you wherever you choose to go. It's no wonder that 90% of medical students in the UK choose to be part of medical protection. You can find out more at medicalprotection.org. Okay, back to the show. So Fi, obviously, as we've di... |
Like Dr. House. Exactly. I think sitting in that identity and being like, actually, I am this person. I'm not just this person. I might change in the future. But actually, this is a really good identity for me to be right now may as well just go full out and get like a pretentious stethoscope with my name on it so I t... |
From the JAMA Network, this is Conversations with Dr. Bauchner, interviews featuring researchers and thinkers in healthcare about their publications in the latest issue of JAMA. Hello and welcome to Conversations with Dr. Bauchner. This is Howard Bauchner, Editor-in-Chief of JAMA, and I am joined by an old and dear fri... |
And then more broadly, Howard, last summer in an announcement that got a lot of attention, the U.S. Business Roundtable, that's about 180 CEOs of the largest companies in the U.S., updated their statement of corporate purpose, saying that appealing to shareholders shouldn't be their only focus, but more broadly, they s... |
Do this together. I'm hoping we can have a healthier society in the future. One last question, Howard. You worked in government for five years. Government has many levers. We've certainly seen they can spend money and then they make law. You were the Assistant Secretary of Health for U.S. Department of Health and Huma... |
Hello, and welcome to this author interview from the JAMA Network. This is Deanna Balandi with JAMA Internal Medicine. Historically, guidelines for screening and management of cervical cancer were simple and clear. But new guidelines have been issued, and some are wondering if they are too complicated. Here to talk abo... |
And similar to Dr. Smith-McCune, I think there should be options. I don't think it's a one-size-fits-all. I think we have to be considering some people will be PAP, some people will be HPV testing. I don't know. It's going to be different for different, and we should have a variety of options available. I like your id... |
Welcome. This is the New England Journal of Medicine. I'm Dr. Michael Bierer. This week, March 19, 2020, we feature articles on discectomy or conservative care for sciatica, no sedation or light sedation in ventilated ICU patients, long-acting therapy to maintain HIV-1 suppression, and a screening program to eliminate ... |
At week 48, an HIV-1 RNA level of 50 copies per milliliter or higher was found in 2.1% of participants who received long-acting therapy and in 2.5% who received oral therapy, a result that met the criterion for non-inferiority for the primary endpoint. An HIV-1 RNA level of less than 50 copies per milliliter at week 48... |
Why should medical training focus on social factors, Goldfarb asked, when medicine's purpose is to cure individual patients? His essay assumed that one can effectively cure patients while ignoring the world in which they live. Unfortunately, that is an empirically untenable position. Social, political, and economic st... |
From the JAMA Network, this is JAMA Cardiology Author Interviews, conversations with authors exploring the latest clinical research, reviews, and opinion featured in JAMA Cardiology. Hello and welcome to this JAMA Cardiology podcast and thank you for joining us. I'm Anne-Marie Navar, Preventive Cardiologist at UT South... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.